AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1.

Transcription factor activating protein 2 (AP2) plays an important role in cellular differentiation. Although profound craniofacial and long bone developmental abnormalities have been observed in AP2-knockout mice, the molecular effects of AP2 on osteoblasts are poorly defined. We demonstrated that AP2 regulates the expression of human Frizzled 1 (FZD1), a co-receptor for the Wnt signalling pathway, in human osteoblast cell lines and primary bone marrow stromal cells (BMSCs). We also identified a putative AP2-binding site in the FZD1 proximal promoter in silico and characterized this binding element further in Saos2 in vitro by ChIP, electrophoretic mobility shift and promoter reporter assays. The transcriptional repression of the FZD1 promoter by AP2 was confirmed in normal human fetal osteoblasts (hFOB). Furthermore, overexpression of AP2 resulted in a significant reduction in both differentiation and mineralization of Saos2 cells. Knockdown of FZD1 expression before AP2 up-regulation diminished the AP2-dependent inhibition of Saos2 cell differentiation and mineralization. Similarly, overexpressing FZD1 before AP2 treatment in both Saos2 and BMSCs diminished the inhibitory effect of AP2 on osteoblast differentiation and mineralization. Taken together, these results demonstrate that AP2 is a negative regulator of osteoblast differentiation and mineralization, and its inhibitory effect may be mediated in part through down-regulation of FZD1 expression.

[1]  L. Yerges-Armstrong,et al.  E2F1 effects on osteoblast differentiation and mineralization are mediated through up-regulation of frizzled-1. , 2013, Bone.

[2]  E. Esen,et al.  WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. , 2013, Cell metabolism.

[3]  M. Amling,et al.  Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin , 2013, The Journal of cell biology.

[4]  Hongli Jiao,et al.  ADAR1 ablation decreases bone mass by impairing osteoblast function in mice. , 2013, Gene.

[5]  P. Neth,et al.  Dissecting the impact of Frizzled receptors in Wnt/β-catenin signaling of human mesenchymal stem cells , 2012, Biological chemistry.

[6]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[7]  Michael B. Eisen,et al.  Control of Embryonic Stem Cell Lineage Commitment by Core Promoter Factor, TAF3 , 2011, Cell.

[8]  G. Sauter,et al.  Control of bone formation by the serpentine receptor Frizzled-9 , 2011, The Journal of cell biology.

[9]  Fanxin Long,et al.  Building strong bones: molecular regulation of the osteoblast lineage , 2011, Nature Reviews Molecular Cell Biology.

[10]  C. Bunker,et al.  Functional and association analysis of frizzled 1 (FZD1) promoter haplotypes with femoral neck geometry. , 2010, Bone.

[11]  A. Bosserhoff,et al.  Roles of AP‐2 transcription factors in the regulation of cartilage and skeletal development , 2010, The FEBS journal.

[12]  G. Roodman,et al.  Critical Role of Activating Transcription Factor 4 in the Anabolic Actions of Parathyroid Hormone in Bone , 2009, PloS one.

[13]  A. Dudley,et al.  Noncanonical frizzled signaling regulates cell polarity of growth plate chondrocytes , 2009, Development.

[14]  J. Cauley,et al.  Functional Characterization of Genetic Variation in the Frizzled 1 (FZD1) Promoter and Association With Bone Phenotypes: More to the LRP5 Story? , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  Ujunwa C. Okoye,et al.  Wnt and Frizzled RNA expression in human mesenchymal and embryonic (H7) stem cells , 2008, Journal of molecular signaling.

[16]  Shibing Yu,et al.  Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expression. , 2008, Endocrinology.

[17]  D. Galson,et al.  General Transcription Factor IIA-γ Increases Osteoblast-specific Osteocalcin Gene Expression via Activating Transcription Factor 4 and Runt-related Transcription Factor 2* , 2008, Journal of Biological Chemistry.

[18]  O. MacDougald,et al.  Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.

[19]  R. Baron,et al.  Wnt signaling: a key regulator of bone mass. , 2006, Current topics in developmental biology.

[20]  Xizhi Guo,et al.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.

[21]  Hans Clevers,et al.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. , 2005, Developmental cell.

[22]  J. Westendorf,et al.  Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.

[23]  P. Sassone-Corsi,et al.  ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology Implication for Coffin-Lowry Syndrome , 2004, Cell.

[24]  R. Baron,et al.  Murine Frizzled-1 Behaves as an Antagonist of the Canonical Wnt/β-Catenin Signaling* , 2004, Journal of Biological Chemistry.

[25]  L. Sandell,et al.  Negative Regulation of Chondrocyte Differentiation by Transcription Factor AP‐2α , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  S. Davies,et al.  Distribution of the Transcription Factors Sox9, AP-2, and [Delta]EF1 in Adult Murine Articular and Meniscal Cartilage and Growth Plate , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[27]  M. Hegen,et al.  A Subtractive Gene Expression Screen Suggests a Role of Transcription Factor AP-2α in Control of Proliferation and Differentiation* , 2002, The Journal of Biological Chemistry.

[28]  R. Tuan,et al.  Frizzled‐7 and limb mesenchymal chondrogenesis: Effect of misexpression and involvement of N‐cadherin , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  R. Buettner,et al.  Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. , 2000, Gene.

[30]  C. Hartmann,et al.  Dual roles of Wnt signaling during chondrogenesis in the chicken limb. , 2000, Development.

[31]  J. Gershenwald,et al.  Loss of AP-2 Results in Up-regulation ofMCAM/MUC18 and an Increase in Tumor Growth and Metastasis of Human Melanoma Cells* , 1998, The Journal of Biological Chemistry.

[32]  T. Shin,et al.  Transcription Factor AP-2 Controls Transcription of the Human Transforming Growth Factor-α Gene* , 1997, The Journal of Biological Chemistry.

[33]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[34]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[35]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[36]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[37]  R. Weigel,et al.  Identification of ERF-1 as a member of the AP2 transcription factor family. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. McMahon,et al.  Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 , 1996, Nature.

[39]  R. Jaenisch,et al.  Transcription factor AP-2 essential for cranial closure and craniofacial development , 1996, Nature.

[40]  T. Williams,et al.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Sarkiss,et al.  N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. , 1994, Genes & development.

[42]  R. Tjian,et al.  Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. , 1991, Genes & development.

[43]  R. Tjian,et al.  Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. , 1991, Science.